Medicine

MIT researchers have discovered a way to make bacteria more vulnerable to a class of antibiotics known as quinolones, which include ciprofloxacin and are often used to treat infections such as Escherichia coli and Staphylococcus aureus.

Boosting the antibiotic arsenal

New strategy could enable existing drugs to kill bacteria that cause chronic infections.

December 7, 2017

Anjali Misra awarded Mitchell Scholarship

MIT senior is headed to Ireland to pursue graduate studies in public health.

November 27, 2017

Through a Bridge Project collaboration with David Weinstock (left) of the Dana-Farber Cancer Institute (DFCI), and MIT Professor Scott Manalis (center), cell-weighing technology is being evaluated in a clinical laboratory at DFCI. MIT visiting scientist Mark Stevens is pictured at right.

Over the river and do some good

The Bridge Project collaboration accelerates new, highly original, and powerful approaches to defeating cancer.

November 22, 2017

Cells pass through an sSMR device, which consists of multiple sensors that are fluidically connected in series and separated by delay channels (not all is shown). This design enables a stream of cells to flow through the device such that different sensors can concurrently weigh flowing cells in the stream.

Cell-weighing method could help doctors choose cancer drugs

Technique may predict which therapies a patient is most sensitive or resistant to.

November 20, 2017

“I think certainly there’s some promise in developing probiotics that could be targeted to possibly fixing some of the effects of a high-salt diet, but people shouldn’t think they can eat fast food and then pop a probiotic, and it will be canceled out,” says MIT Professor Eric Alm.

Gut microbes can protect against high blood pressure

Strain of intestinal bacteria can stop a high-salt diet from inducing inflammatory response linked to hypertension.

November 15, 2017

In a new study, MIT researchers have developed nanoparticles that can deliver the CRISPR genome-editing system and specifically modify genes, eliminating the need to use viruses for delivery.

CRISPR-carrying nanoparticles edit the genome

New delivery system developed by MIT team deletes disease-causing genes and reduces cholesterol.

November 13, 2017

MIT senior Mary Clare Beytagh hopes to become a science writer as well as a physician-scientist, telling stories that humanize patients and focus on the social and economic determinants of health.

Mary Clare Beytagh: Finding poetry in medicine

MIT senior and aspiring physician aims to tell stories that humanize the patients behind medical statistics.

November 12, 2017

MIT NEWDIGS Design Lab advances work on medical treatment financing strategies

Industry leaders, patient advocates, and policymakers collaborate to make groundbreaking new therapies economically sustainable.

November 9, 2017

The mTOR cellular pathway connects nutrition, metabolism, and disease.

New player in cellular signaling

Researchers have identified a key nutrient sensor in the mTOR pathway that links nutrient availability to cell growth.

November 9, 2017

Researchers have developed a new method for making “blood biopsies” for cancer more effective by using whole exome sequencing to monitor tumor DNA from blood samples.

New techniques give blood biopsies greater promise

Improved methods validate the use of blood samples for studying patients’ cancer genomes.

November 6, 2017

MIT Medical fell short of its goal of 10,000 flu shots in one day, but it still managed to smash the previous one-day record for flu shots given.

MIT Medical shatters one-day flu shot record

This year’s clinic lived up to its reputation as one of the most efficient operations at MIT.

November 1, 2017

A nutrient mix based in part on research from the lab of MIT Professor Emeritus Richard Wurtman has shown promise in treating the early stages of Alzheimer’s disease.

MIT research laid groundwork for promising Alzheimer’s-fighting drink

Studies by Richard Wurtman have led to development of nutrient mix shown to slow cognitive impairment in early stages of the disease.

October 30, 2017

Pictured, left to right, are: Manisha Bahl, director of the Massachusetts General Hospital Breast Imaging Fellowship Program; MIT Professor Regina Barzilay (center); and Constance Lehman, professor at Harvard Medical School and chief of the Breast Imaging Division at MGH’s Department of Radiology.

Using artificial intelligence to improve early breast cancer detection

Model developed at MIT’s Computer Science and Artificial Intelligence Laboratory could reduce false positives and unnecessary surgeries.

October 16, 2017

Elazer Edelman and his students have been credited as some of the key contributors and pioneers of the coronary stent.

Elazer Edelman honored with Cardiovascular Research Foundation career achievement award

The 2017 Transcatheter Cardiovascular Therapeutics Career Achievement Award honors a pioneering biomedical engineer, scientist, professor, and cardiologist.

October 13, 2017

In this image, lung cancer driven by the KRAS oncogene shows up in purple. MIT biologists have found a potential new way to treat this type of lung tumor, long thought to be “undruggable."

New target for treating “undruggable” lung cancer

Drug already in clinical trials may be effective on some aggressive adenocarcinomas.

October 2, 2017

MIT News | Massachusetts Institute of Technology - On Campus and Around the world

Browse By

Topics

Departments

Centers, Labs, & Programs

Schools

Topic